Spiroxatrine (R 5188) is a selective and potent 5-HT1alpha and alpha2-adrenergic dual antagonist with sedative activity, and inhibitory effects on 5-HT1alpha, 5-HT1beta, 5-HT2, and dopamine receptors. Spiroxatrine may be used in the study of disorders related to the cardiovascular system.